Stocks News

LAST PRICE
22.7300
TODAY'S CHANGE (%)
Trending Up0.2100 (0.9325%)

Bid / Lots
21.3900/ 1
Ask / Lots
27.1500/ 10
Open / Previous Close
22.6000 / 22.5200
Day Range
Low 22.5200
High 23.5400
52 Week Range
Low 12.5400
High 28.9100
Volume
143,698
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%, from 23 hours ago by MT Newswires
  23 hours ago by MT Newswires
  Companies Mentioned: BBVA, LYG, NCNA, OPRA, GNFT, MREO, BCYC, BHP, EVAX, BP, MTLS, ASND, CUK, CLLS, BDRX, EDAP
  11:09 AM EDT, 04/26/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending higher Friday morning, rising 0.5% to 1,380.32 on the S&P Europe Select ADR Index. With the gain, the index is set to close o...
Apr 24, 2024
- Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting, from 10:05AM ET on Wednesday Apr 24, 2024 by Business Wire
  10:05AM ET on Wednesday Apr 24, 2024 by Business Wire
  Companies Mentioned: BCYC
  Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle(R)) technology, today announced the acceptance of two abstracts for poster presentation at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting, taking place May 31-June 4 in Chicago.
- Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting, from 10:05AM ET on Wednesday Apr 24, 2024 by Dow Jones
  10:05AM ET on Wednesday Apr 24, 2024 by Dow Jones
  Companies Mentioned: BCYC
  CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--April 24, 2024--
  Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle(R) ) technology, today announced the acceptance of two abstracts for poster presentation at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting, taking place May 31-June 4 in Chicago.
Apr 22, 2024
- European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading, from 11:03AM ET on Monday Apr 22, 2024 by MT Newswires
  11:03AM ET on Monday Apr 22, 2024 by MT Newswires
  Companies Mentioned: AVDL, FMS, NOK, VOD, VRNA, NCNA, GNFT, AKTX, BCYC, CALT, TCBP, DBVT, CLLS, BDRX
  11:03 AM EDT, 04/22/2024 (MT Newswires) -- After closing out last week more than 2% lower, European equities traded in the US as American depositary receipts rebounded Monday morning, rising 1.09% to 1,340.58 on the S&P Europe Select ADR Index. From...
Apr 19, 2024
- European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down, from 11:10AM ET on Friday Apr 19, 2024 by MT Newswires
  11:10AM ET on Friday Apr 19, 2024 by MT Newswires
  Companies Mentioned: SQNS, NCNA, AMRN, AUTL, OPRA, DAVA, BCYC, CALT, SLN, BPTSY, BP, DBVT, ASND, CLLS, ADAP, EDAP
  11:10 AM EDT, 04/19/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending higher Friday morning, rising 0.46% to 1,330.20 on the S&P Europe Select ADR Index. Despite the gain, the index remains on pa...

Apr 25, 2024
- Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024, from 4:06PM ET on Thursday Apr 25, 2024 by GlobeNewswire
  4:06PM ET on Thursday Apr 25, 2024 by GlobeNewswire
  Companies Mentioned: RLAY
- Immunome Appoints Sandra M. Swain to Board of Directors, from 8:26AM ET on Thursday Apr 25, 2024 by Business Wire
  8:26AM ET on Thursday Apr 25, 2024 by Business Wire
  Companies Mentioned: IMNM
Apr 22, 2024
- SS Innovations International Announces Q1 2024 Company Updates, from 8:00AM ET on Monday Apr 22, 2024 by GlobeNewswire
  8:00AM ET on Monday Apr 22, 2024 by GlobeNewswire
  Companies Mentioned: SSII
Apr 15, 2024
- --Guggenheim Starts Immunome With Buy Rating, $35 Price Target, from 8:35AM ET on Monday Apr 15, 2024 by MT Newswires
  8:35AM ET on Monday Apr 15, 2024 by MT Newswires
  Companies Mentioned: IMNM
Apr 11, 2024
- Relay Therapeutics to Participate in Upcoming Investor Conferences, from 4:05PM ET on Thursday Apr 11, 2024 by GlobeNewswire
  4:05PM ET on Thursday Apr 11, 2024 by GlobeNewswire
  Companies Mentioned: RLAY
Apr 10, 2024
- SS Innovations' Flagship SSi Mantra Surgical Robotic Device Successfully Completes Telesurgery Procedures, from 8:00AM ET on Wednesday Apr 10, 2024 by GlobeNewswire
  8:00AM ET on Wednesday Apr 10, 2024 by GlobeNewswire
  Companies Mentioned: SSII
Apr 5, 2024
- Immunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual Meeting, from 8:00AM ET on Friday Apr 05, 2024 by Business Wire
  8:00AM ET on Friday Apr 05, 2024 by Business Wire
  Companies Mentioned: IMNM
Apr 4, 2024
- Cantor Fitzgerald Initiates Coverage on Tango Therapeutics With Overweight Rating, from 10:09AM ET on Thursday Apr 04, 2024 by MT Newswires
  10:09AM ET on Thursday Apr 04, 2024 by MT Newswires
  Companies Mentioned: TNGX
Apr 1, 2024
- Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:48PM ET on Monday Apr 01, 2024 by Business Wire
  4:48PM ET on Monday Apr 01, 2024 by Business Wire
  Companies Mentioned: TNGX
- --Wedbush Adjusts Immunome's Price Target to $33 From $27, Maintains Outperform Rating, from 7:44AM ET on Monday Apr 01, 2024 by MT Newswires
  7:44AM ET on Monday Apr 01, 2024 by MT Newswires
  Companies Mentioned: IMNM

Bicycle Therapeutics PLC
NASDAQ:BCYCUnited States

Search Criteria

Yesterday

European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%, from 23 hours ago by MT Newswires

Apr 24, 2024

Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting, from 10:05AM ET on Wednesday Apr 24, 2024 by Business Wire

Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting, from 10:05AM ET on Wednesday Apr 24, 2024 by Dow Jones

Apr 22, 2024

European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading, from 11:03AM ET on Monday Apr 22, 2024 by MT Newswires

Apr 19, 2024

European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down, from 11:10AM ET on Friday Apr 19, 2024 by MT Newswires

Peers Headlines

Apr 25, 2024

Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024, from 4:06PM ET on Thursday Apr 25, 2024 by GlobeNewswire

Immunome Appoints Sandra M. Swain to Board of Directors, from 8:26AM ET on Thursday Apr 25, 2024 by Business Wire

Apr 22, 2024

SS Innovations International Announces Q1 2024 Company Updates, from 8:00AM ET on Monday Apr 22, 2024 by GlobeNewswire

Apr 15, 2024

--Guggenheim Starts Immunome With Buy Rating, $35 Price Target, from 8:35AM ET on Monday Apr 15, 2024 by MT Newswires

Apr 11, 2024

Relay Therapeutics to Participate in Upcoming Investor Conferences, from 4:05PM ET on Thursday Apr 11, 2024 by GlobeNewswire

Apr 10, 2024

SS Innovations' Flagship SSi Mantra Surgical Robotic Device Successfully Completes Telesurgery Procedures, from 8:00AM ET on Wednesday Apr 10, 2024 by GlobeNewswire

Apr 5, 2024

Immunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual Meeting, from 8:00AM ET on Friday Apr 05, 2024 by Business Wire

Apr 4, 2024

Cantor Fitzgerald Initiates Coverage on Tango Therapeutics With Overweight Rating, from 10:09AM ET on Thursday Apr 04, 2024 by MT Newswires

Apr 1, 2024

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:48PM ET on Monday Apr 01, 2024 by Business Wire

--Wedbush Adjusts Immunome's Price Target to $33 From $27, Maintains Outperform Rating, from 7:44AM ET on Monday Apr 01, 2024 by MT Newswires